{
    "startDate": "2018-01-01",
    "endDate": "2018-09-30",
    "year": "2018",
    "quarter": "Q3",
    "symbol": "AKCA",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 116206000
            },
            {
                "label": "Short-term investments",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 204109000
            },
            {
                "label": "Contract receivable",
                "concept": "ContractWithCustomerAssetNetCurrent",
                "unit": "usd",
                "value": 636000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 8397000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 329348000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 5757000
            },
            {
                "label": "Licenses, net",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 40969000
            },
            {
                "label": "Deposits and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 3054000
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 379128000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 3071000
            },
            {
                "label": "Payable to Ionis Pharmaceuticals, Inc.",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 23888000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 8848000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 21151000
            },
            {
                "label": "Current portion of deferred revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 32347000
            },
            {
                "label": "Other current liabilities",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 1295000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 90600000
            },
            {
                "label": "Long-term portion of deferred rent",
                "concept": "DeferredRentCreditNoncurrent",
                "unit": "usd",
                "value": 4653000
            },
            {
                "label": "Long-term portion of deferred revenue",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 2464000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 97717000
            },
            {
                "label": "Common stock, $0.001 par value; 125,000,000 and 100,000,000 shares authorized at September 30, 2018 and December 31, 2017, respectively; 87,471,330 and 66,541,629 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 87000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 733098000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -289000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -451485000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 281411000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 379128000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -155264000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 109000
            },
            {
                "label": "Amortization of licenses",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 815000
            },
            {
                "label": "Amortization of premium on investments, net",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": -197000
            },
            {
                "label": "Non-cash sublicensing expenses under the development, commercialization and license agreement and services agreement with Ionis related to the drugs licensed under the agreement.. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.",
                "concept": "akca:NonCashSublicensingExpense",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Interest paid other than in cash for a line of credit with a related party,. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.",
                "concept": "akca:NonCashInterestExpenseForLineOfCreditRelatedParty",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Stock-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 31239000
            },
            {
                "label": "Contracts receivable",
                "concept": "IncreaseDecreaseInContractWithCustomerAsset",
                "unit": "usd",
                "value": -4777000
            },
            {
                "label": "Other current and long-term assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 7104000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 300000
            },
            {
                "label": "Payable to Ionis Pharmaceuticals, Inc.",
                "concept": "IncreaseDecreaseInDueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 9198000
            },
            {
                "label": "Accrued compensation",
                "concept": "IncreaseDecreaseInOtherEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": 4765000
            },
            {
                "label": "The increase (decrease) during the reporting period in the aggregate amount of deferred rent due within one year or operating cycle.",
                "concept": "akca:IncreaseDecreaseInDeferredRent",
                "unit": "usd",
                "value": 1018000
            },
            {
                "label": "Accrued liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 12219000
            },
            {
                "label": "Income taxes payable",
                "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
                "unit": "usd",
                "value": -553000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": -35882000
            },
            {
                "label": "Operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -134166000
            },
            {
                "label": "Purchases of short-term investments",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 105091000
            },
            {
                "label": "Proceeds from sale of short-term investments",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 138580000
            },
            {
                "label": "Purchase of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 116000
            },
            {
                "label": "Investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 33373000
            },
            {
                "label": "Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement and issuances of stock from employee stock purchase plan.",
                "concept": "akca:ProceedsFromStockOptionsExercisedAndEmployeeStockPurchaseIssuances",
                "unit": "usd",
                "value": 5141000
            },
            {
                "label": "Proceeds from issuance of common stock, net of underwriters' discount",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from sale of common stock to Novartis in private placement",
                "concept": "ProceedsFromIssuanceOfPrivatePlacement",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from line of credit from Ionis Pharmaceuticals, Inc.",
                "concept": "ProceedsFromRepaymentsOfRelatedPartyDebt",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net proceeds from issuance of common stock to Ionis in connection with TTR License Agreement",
                "concept": "ProceedsFromIssuanceOrSaleOfEquity",
                "unit": "usd",
                "value": 155856000
            },
            {
                "label": "Offering costs paid",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 160997000
            },
            {
                "label": "Effect of exchange rates on cash",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": 19000
            },
            {
                "label": "Net increase in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 60223000
            },
            {
                "label": "Future cash outflow to pay for deferred offering costs attributable to an offering of securities that have been incurred.",
                "concept": "akca:UnpaidDeferredOfferingCosts",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Conversion of line of credit from Ionis Pharmaceuticals, Inc. into common stock",
                "concept": "StockIssued1",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Purchase of property, plant and equipment included in accounts payable and accrued liability",
                "concept": "CapitalExpendituresIncurredButNotYetPaid",
                "unit": "usd",
                "value": 1752000
            },
            {
                "label": "Purchase of property, plant and equipment included in long-term deferred rent liability",
                "concept": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
                "unit": "usd",
                "value": 3596000
            },
            {
                "label": "Acquisition of research and development licenses and milestone payments",
                "concept": "NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1",
                "unit": "usd",
                "value": 40563000
            }
        ],
        "ic": [
            {
                "label": "Revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 54670000
            },
            {
                "label": "Cost of sales - intangible asset amortization",
                "concept": "CostOfGoodsAndServicesSoldAmortization",
                "unit": "usd",
                "value": 701000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 96808000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 107676000
            },
            {
                "label": "Expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 213428000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -158758000
            },
            {
                "label": "Investment income",
                "concept": "InvestmentIncomeNet",
                "unit": "usd",
                "value": 4089000
            },
            {
                "label": "Other income (expense)",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -148000
            },
            {
                "label": "Loss before income tax expense",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -154817000
            },
            {
                "label": "Income tax expense",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 447000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -155264000
            },
            {
                "label": "Unrealized gains (losses) on investments, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 143000
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 19000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -155102000
            }
        ]
    }
}